Sherbrooke Park Advisers LLC Amphastar Pharmaceuticals, Inc. Transaction History
Sherbrooke Park Advisers LLC
- $436 Billion
- Q3 2024
A detailed history of Sherbrooke Park Advisers LLC transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Sherbrooke Park Advisers LLC holds 7,140 shares of AMPH stock, worth $273,247. This represents 0.08% of its overall portfolio holdings.
Number of Shares
7,140
Previous 15,147
52.86%
Holding current value
$273,247
Previous $606 Million
42.81%
% of portfolio
0.08%
Previous 0.11%
Shares
3 transactions
Others Institutions Holding AMPH
# of Institutions
286Shares Held
34.9MCall Options Held
74.3KPut Options Held
22.3K-
Black Rock Inc. New York, NY5.94MShares$227 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.71MShares$104 Million0.0% of portfolio
-
Td Asset Management Inc2.14MShares$81.7 Million0.1% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.95MShares$74.5 Million0.22% of portfolio
-
Neuberger Berman Group LLC New York, NY1.62MShares$61.8 Million0.06% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.88B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...